Pharmaceutical Sciences
Scope & Guideline
Bridging research and practice to transform healthcare.
Introduction
Aims and Scopes
- Drug Development and Formulation:
The journal emphasizes the process of drug discovery and formulation, focusing on novel drug delivery systems, formulation techniques, and the physicochemical properties that affect drug efficacy. - Nanotechnology and Drug Delivery Systems:
There is a significant focus on the integration of nanotechnology in pharmaceutical sciences, including the design and evaluation of nanoparticles, nanocarriers, and their applications in improving drug bioavailability and targeting. - Clinical Pharmacology and Therapeutics:
Research on the clinical efficacy and safety of drugs, including randomized controlled trials and pharmacoeconomic analyses, is a core area, providing evidence-based insights into therapeutic interventions. - Biopharmaceuticals and Biotechnology:
The journal explores biopharmaceutical advancements, including monoclonal antibodies, vaccines, and biologics, along with their formulation and delivery challenges. - Natural Products and Herbal Medicine:
There is a growing interest in the pharmacological evaluation of natural products, herbal formulations, and their potential therapeutic roles, which is reflected in numerous articles addressing their efficacy and mechanisms. - Toxicology and Safety Assessments:
The journal includes studies on the toxicity and safety of pharmaceutical compounds, including preclinical and clinical evaluations, which are crucial for regulatory approvals. - Pharmacogenomics and Personalized Medicine:
Research into how genetic variations affect individual responses to drugs, paving the way for personalized therapeutic strategies, is increasingly represented in the journal.
Trending and Emerging
- Nanomedicine and Targeted Therapies:
There is a marked increase in research focused on nanomedicine, including targeted drug delivery systems that enhance therapeutic efficacy while minimizing side effects, indicating a shift towards more precise treatment modalities. - Artificial Intelligence in Drug Discovery:
The application of artificial intelligence and machine learning in drug discovery processes is rapidly emerging, facilitating faster and more efficient identification of potential drug candidates and optimization of formulations. - Biologics and Biosimilars:
Research into biologics, including monoclonal antibodies and biosimilars, is on the rise, reflecting the growing importance of these therapies in treating chronic and complex diseases. - Personalized and Precision Medicine:
There is a growing emphasis on personalized medicine approaches that tailor treatments based on individual genetic profiles, leading to improved patient outcomes and reduced adverse effects. - Sustainable and Green Chemistry:
The incorporation of green chemistry principles in pharmaceutical development is becoming increasingly relevant, as researchers seek to minimize environmental impacts and enhance the sustainability of pharmaceutical processes. - Pharmacogenomics and Tailored Therapies:
Research exploring the intersection of pharmacogenomics and tailored therapeutic strategies is gaining momentum, highlighting the importance of genetic factors in drug metabolism and efficacy.
Declining or Waning
- Traditional Pharmaceutical Chemistry:
The emphasis on classical synthetic organic chemistry methods has waned, with a noticeable decrease in publications focused solely on traditional chemical synthesis without the integration of modern techniques such as computer-aided drug design or nanotechnology. - Invasive Clinical Trials:
There has been a shift away from invasive clinical trials in favor of non-invasive methods and observational studies, reflecting a broader trend towards patient safety and ethical considerations in clinical research. - Conventional Drug Formulations:
Research on conventional drug formulations, particularly those lacking innovative delivery methods, is declining as the field moves towards more sophisticated, targeted, and personalized drug delivery systems. - Single-Target Drug Approaches:
The focus on single-target drug discovery is decreasing, with a growing preference for polypharmacology and combination therapies that target multiple pathways for more effective treatment outcomes.
Similar Journals
Advances in Pharmacological and Pharmaceutical Sciences
Pioneering Insights in Toxicology and Drug Development.Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
Empowering Insights in Assay Technologies and TherapeuticsASSAY AND DRUG DEVELOPMENT TECHNOLOGIES is a peer-reviewed journal published by Mary Ann Liebert, Inc., focused on the innovative fields of pharmacology and drug development. With its ISSN 1540-658X and E-ISSN 1557-8127, the journal has successfully contributed to the scientific community since its inception in 2002, converging into one comprehensive resource by 2024. Positioned in the Q3 quartile for Drug Discovery and Q4 for Molecular Medicine as per the 2023 rankings, the journal is dedicated to disseminating cutting-edge research that addresses the complexities of drug assay techniques and their implications in therapeutics. Although currently not an open-access publication, it offers significant insights and findings valuable to researchers, professionals, and students in the realm of biochemistry and pharmacology. With a commitment to advancing knowledge and innovation, ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES continues to be an essential platform for the latest advancements in drug discovery and development.
Frontiers in Pharmacology
Exploring innovative pathways in pharmacological research.Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.
Pharmaceutics
Empowering researchers to shape the future of therapeutics.Pharmaceutics is a prestigious journal published by MDPI, specializing in the field of pharmaceutical sciences. With its Open Access model established in 2010, it promotes the dissemination of cutting-edge research, catering to a global audience of researchers, professionals, and students alike. Based in Switzerland, the journal has rapidly gained recognition, currently holding an impressive Q1 ranking in the pharmaceutical science category for 2023 and achieving a Scopus ranking of #32 out of 183 in the domain of Pharmacology, Toxicology, and Pharmaceutics, placing it in the 82nd percentile. The journal's objectives include advancing knowledge in drug formulation, delivery systems, and therapeutic applications, ensuring that published works contribute significantly to both academic discourse and practical applications in the pharmaceutical industry. As part of its commitment to excellence, Pharmaceutics welcomes high-quality manuscripts that inspire innovation and foster collaboration in this vital field.
Turkish Journal of Pharmaceutical Sciences
Pioneering Insights in Drug Development and TherapeuticsThe Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
Advancing pharmaceutical knowledge, one article at a time.YAKUGAKU ZASSHI - JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, published by the Pharmaceutical Society of Japan, is a key academic journal dedicated to advancing the field of pharmaceutical sciences. Established in 1961 and set to contribute until 2024, this journal publishes original research articles, reviews, and clinical studies that encompass a wide spectrum of topics within pharmacology, toxicology, and pharmaceutics. Although the journal operates under a traditional subscription model, it maintains a recognized reputation with an impact factor that is steadily aligned within its category quartiles—ranking Q3 in Pharmaceutical Science and Q4 in Pharmacology as of 2023. With Scopus rankings reflecting its competitive standing, YAKUGAKU ZASSHI serves as a vital resource for researchers, professionals, and students looking to engage with innovative findings and broaden their understanding of pharmaceutical methodologies and research practices. With a current focus on bridging scientific research with real-world applications, it seeks to foster collaboration and knowledge sharing within the pharmaceutical community.
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Fostering Excellence in Biomedical and Pharmaceutical DiscourseBIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.
Brazilian Journal of Pharmaceutical Sciences
Unveiling the Future of Pharmaceutics Through Open Access.The Brazilian Journal of Pharmaceutical Sciences is a prestigious and peer-reviewed journal dedicated to disseminating significant research across the fields of Pharmacology, Toxicology, and Pharmaceutics. Published by UNIV SAO PAULO, CONJUNTO QUIMICAS, this journal has been an Open Access platform since 2009, making it accessible to a global audience, fostering collaboration and knowledge sharing among researchers and professionals. With an ISSN of 1984-8250 and an E-ISSN of 2175-9790, it holds a respectable Q3 ranking in these fields for 2023, indicating its contribution to the scientific community's understanding and advancement of pharmaceutical sciences. As it converges from 2009 to 2024, the journal continues to address emerging trends and critical topics in drug development, safety, and efficacy, positioning itself as an essential resource for students, researchers, and practitioners seeking to contribute to and stay informed about advancements in pharmacological research. With its publication address in São Paulo, Brazil, the journal serves as a key outlet for Brazilian and international scholars alike.
Istanbul Journal of Pharmacy
Empowering research, enhancing pharmacy practice.Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Elevating Knowledge in Pharmaceutical BiotechnologyCURRENT PHARMACEUTICAL BIOTECHNOLOGY is a prestigious academic journal dedicated to advancing the field of pharmaceutical biotechnology by publishing high-quality research articles, reviews, and innovatory methodologies. Published by Bentham Science Publishers Ltd, this journal has established a strong reputation in its field, reflected in its 2023 Scopus rankings: it holds an impressive Q2 classification in Pharmaceutical Science and Q3 in Biotechnology, indicating its significant impact within these disciplines. With an ISSN of 1389-2010 and an E-ISSN of 1873-4316, CURRENT PHARMACEUTICAL BIOTECHNOLOGY provides a reliable platform for disseminating valuable research findings and fostering collaboration among researchers, professionals, and students alike. The journal covers a wide array of topics, from drug development and delivery systems to innovative biotechnological techniques, thus serving as an essential resource for anyone interested in the cross-section of pharmaceutical science and biotechnology. Researchers can access a diverse range of articles that explore both theoretical frameworks and practical applications, reflecting the ongoing evolution and challenges in this dynamic field.